Skip to main content
. 2013 Aug 8;8(8):e73639. doi: 10.1371/journal.pone.0073639

Figure 3. Proportion of patients with HIV RNA <50 copies/ml at 24 and 48 weeks.

Figure 3

(A) Per protocol analysis. (B) Intention-to-treat analysis. VL, viral load; RAL, raltegravir; DRV/r, ritonavir-boosted darunavir; LPV/r, ritonavir-boosted lopinavir; TVD, fixed dose of tenofovir/emtricitabine.